Series D funding round for Vivace Therapeutics raising $35M in March 2025
Series D funding round for Vivace Therapeutics raising $35M in March 2025
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$90M
Top Valuation
-
Vivace Therapeutics raised $35M in a Series D round.
The round was announced on 03/01/25.
The round was led by RA Capital Management.